Press Releases on Abortion

WASHINGTON, D.C., Feb. 25, 2019—Russell Moore, president of the Ethics & Religious Liberty Commission of the Southern Baptist Convention, is urging U.S. Senators to vote “yes” in support of the Born-Alive Abortion Survivors Protection Act, which is scheduled for a... Continue...

WASHINGTON, D.C., Jan. 30, 2019—Russell Moore, president of the Ethics & Religious Liberty Commission of the Southern Baptist Convention, called Virginia Gov. Ralph Northam’s comments on a proposed abortion bill “nothing short of horrifying, and a shock to any functioning... Continue...

WASHINGTON, D.C., May 18, 2018—Russell Moore, president of the Southern Baptist Convention’s Ethics & Religious Liberty Commission, commented on reports that the Trump administration will announce today its intent to propose a rule to reinstate Title X regulations that would... Continue...

NASHVILLE, Tenn., May 3, 2017—Russell Moore, president of the Ethics & Religious Liberty Commission of the Southern Baptist Convention, applauded the passage of the “Tennessee Infants Protection Act” (SB 1180/HB 1189) by the Tennessee Legislature. This bill, once signed into... Continue...

WASHINGTON, D.C., Jan. 23, 2017—Russell Moore, president of the Southern Baptist Convention’s Ethics & Religious Liberty Commission, commended President Trump on his decision to reinstate the Mexico City Policy today, that bans funds for international organizations that perform or promote... Continue...

WASHINGTON, D.C.—Russell Moore, president of the Ethics & Religious Liberty Commission of the Southern Baptist Convention, commented today on the U.S. Supreme Court decision denying the rights of states to enact common sense regulations on abortion in Whole Woman’s Health... Continue...

Russell Moore responds to President Obamas veto of legislation to defund Planned Parenthood Continue...

ERLC President Russell Moore Responds to Supreme Court Decision to Hear Challenge to Texas Abortion Law Continue...

Russell Moore Responds to Planned Parenthoods Change to Its Fetal-Tissue Reimbursement Policy Continue...